From USFDA
Zydus Cadila has received final approval from USFDA to market Metoprolol Succinate Extended Release Tablets USP in the strengths of 25 mg, 50 mg, 100 mg and 200 mg. The drug is used to treat chest pain (angina), heart failure and high blood pressure. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content